Lessons Learned from Alternative Methods and their Validation for a New Toxicology in the 21st Century
暂无分享,去创建一个
[1] W. Russell,et al. Ethical and Scientific Considerations Regarding Animal Testing and Research , 2011, PloS one.
[2] T Hartung,et al. The use of embryonic stem cells for regulatory developmental toxicity testing in vitro--the current status of test development. , 2004, Current pharmaceutical design.
[3] Thomas Hartung,et al. Food for thought... on animal tests. , 2008, ALTEX.
[4] Valérie Zuang,et al. A Modular Approach to the ECVAM Principles on Test Validity , 2004, Alternatives to laboratory animals : ATLA.
[5] Steven K. Gibb. Toxicity testing in the 21st century: a vision and a strategy. , 2008, Reproductive toxicology.
[6] Thomas Hartung,et al. Points of Reference in the Validation Process , 2008, Alternatives to laboratory animals : ATLA.
[7] Raymond S. H. Yang. Commentary: some critical issues and concerns related to research advances on the toxicology of chemical mixtures , 1998, Environmental Health Perspectives.
[8] R D Combes,et al. Early microdose drug studies in human volunteers can minimise animal testing: Proceedings of a workshop organised by Volunteers in Research and Testing. , 2003, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[9] M. Leist,et al. Food for thought... on the real success of 3R approaches. , 2008, ALTEX.
[10] Thomas Hartung,et al. Optimisation of the Post-validation Process , 2008, Alternatives to laboratory animals : ATLA.
[11] Michael Schwarz,et al. The integrated project ReProTect: a novel approach in reproductive toxicity hazard assessment. , 2005, Reproductive toxicology.
[12] Thomas Hartung,et al. A Toxicology for the 21st Century—Mapping the Road Ahead , 2009, Toxicological sciences : an official journal of the Society of Toxicology.
[13] Thomas Hartung,et al. Re-evaluation of animal numbers and costs for in vivo tests to accomplish REACH legislation requirements for chemicals - a report by the transatlantic think tank for toxicology (t(4)). , 2009, ALTEX.
[14] Robert Kavlock,et al. The U.S. Environmental Protection Agency Strategic Plan for Evaluating the Toxicity of Chemicals , 2010, Journal of toxicology and environmental health. Part B, Critical reviews.
[15] Thomas Hartung,et al. The dawning of a new age of toxicology. , 2008, ALTEX.
[16] R. S. Thomas,et al. Approaches to developing alternative and predictive toxicology based on PBPK/PD and QSAR modeling. , 1998, Environmental health perspectives.
[17] George Loizou,et al. Characterizing uncertainty and variability in physiologically based pharmacokinetic models: state of the science and needs for research and implementation. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.
[18] Thomas Hartung,et al. Food for thought ... on globalisation of alternative methods. , 2007, ALTEX.
[19] L. L. Smith,et al. Key challenges for toxicologists in the 21st century. , 2001, Trends in pharmacological sciences.
[20] Thomas Hartung,et al. Food for thought ... on the evolution of toxicology and the phasing out of animal testing. , 2008, ALTEX.
[21] F. Collins,et al. Transforming Environmental Health Protection , 2008, Science.
[22] Thomas Hartung,et al. Chemical regulators have overreached , 2009, Nature.
[23] Thomas Hartung,et al. Barriers to Validation , 2008 .
[24] T. Hartung,et al. Alternatives to animal experimentation in basic research. , 2004, ALTEX.
[25] T Seidle,et al. The development of new concepts for assessing reproductive toxicity applicable to large scale toxicological programmes. , 2007, Current pharmaceutical design.
[26] T. Hartung. Toxicology for the twenty-first century , 2009, Nature.
[27] Sebastian Hoffmann,et al. Food for thought ... on in silico methods in toxicology. , 2009, ALTEX.
[28] Thomas Hartung,et al. Food for thought... on cell culture. , 2007, ALTEX.
[29] Gianni Dal Negro,et al. Barriers to validation: a report by the European Partnership fo Alternative Approaches to Animal Testing (EPAA) Working Group 5. , 2008, Alternatives to laboratory animals : ATLA.
[30] T Hartung,et al. Toward an evidence-based toxicology , 2006, Human & experimental toxicology.
[31] Helmut Greim,et al. Toxicological comments to the discussion about REACH , 2006, Archives of Toxicology.
[32] Michael Balls. [The three Rs: looking back ... and forward]. , 2005, ALTEX.
[33] Coecke Sandra,et al. Validation of Toxicogenomics-Based Test Systems:ECVAM-ICCVAM/NICEATM Considerations for Regulatory Use , 2006 .
[34] Michael Balls,et al. Guidance on Good Cell Culture Practice , 2005, Alternatives to laboratory animals : ATLA.
[35] Sebastian Hoffmann,et al. Diagnosis: toxic!--trying to apply approaches of clinical diagnostics and prevalence in toxicology considerations. , 2005, Toxicological sciences : an official journal of the Society of Toxicology.
[36] D Parent-Massin,et al. Application of the CFU-GM assay to predict acute drug-induced neutropenia: an international blind trial to validate a prediction model for the maximum tolerated dose (MTD) of myelosuppressive xenobiotics. , 2003, Toxicological sciences : an official journal of the Society of Toxicology.
[37] J. Bailar,et al. Toxicity Testing in the 21st Century: A Vision and a Strategy , 2010, Journal of toxicology and environmental health. Part B, Critical reviews.
[38] Robert J. Kavlock. The future of toxicity testing—The NRC vision and the EPA's ToxCast program national center for computational toxicology , 2009 .
[39] T. Hartung,et al. Food for thought ... On food safety testing. , 2008, ALTEX.
[40] T Seidle,et al. Bringing toxicology into the 21st century: a global call to action. , 2009, Toxicology in vitro : an international journal published in association with BIBRA.
[41] Thomas Hartung,et al. Food for thought... on the economics of animal testing. , 2009, ALTEX.
[42] Melvin E. Andersen,et al. The need for a new toxicity testing and risk analysis paradigm to implement REACH or any other large scale testing initiative , 2006, Archives of Toxicology.
[43] C. Eskes,et al. Alternative (non-Animal) Methods for Cosmetics Testing : Current Status and Future Prospects. A Report Prepared in the Context of the 7th Amendment to the Cosmetics Directive for Establishing the Timetable for Phasing Out Animal Testing , 2005 .
[44] Andrew Worth,et al. ECVAM's Response to the Changing Political Environment for Alternatives: Consequences of the European Union Chemicals and Cosmetics Policies , 2003, Alternatives to laboratory animals : ATLA.
[45] Thomas Hartung,et al. Are in vitro tests suitable for regulatory use? , 2009, Toxicological sciences : an official journal of the Society of Toxicology.
[46] Christina Grindon,et al. A review of the status of alternative approaches to animal testing and the development of integrated testing strategies for assessing the toxicity of chemicals under REACH--a summary of a DEFRA-funded project conducted by Liverpool John Moores University and FRAME. , 2006, Alternatives to laboratory animals : ATLA.
[47] Harvey J Clewell,et al. Development and specification of physiologically based pharmacokinetic models for use in risk assessment. , 2008, Regulatory toxicology and pharmacology : RTP.
[48] Thomas Hartung,et al. Food for thought... on evidence-based toxicology. , 2009, ALTEX.
[49] B. Latour,et al. Laboratory Life: The Construction of Scientific Facts , 1979 .
[50] Robert J Kavlock,et al. Toxicity Testing in the 21st Century: Implications for Human Health Risk Assessment , 2009, Risk analysis : an official publication of the Society for Risk Analysis.
[51] Christina Rudén,et al. The use of mechanistic data and the handling of scientific uncertainty in carcinogen risk assessments. The trichloroethylene example. , 2002, Regulatory toxicology and pharmacology : RTP.
[52] T. Hartung. Food for thought ... on validation. , 2007, ALTEX.
[53] Raffaella Corvi,et al. The carcinoGENOMICS project: critical selection of model compounds for the development of omics-based in vitro carcinogenicity screening assays. , 2008, Mutation research.
[54] Hugh A Barton,et al. Evaluation of physiologically based pharmacokinetic models for use in risk assessment , 2007, Journal of applied toxicology : JAT.
[55] Thomas Hartung,et al. Toward a New Toxicology — Evolution or Revolution? , 2008, Alternatives to laboratory animals : ATLA.
[56] B. Blaauboer,et al. Factors stimulating or obstructing the implementation of the 3Rs in the regulatory process. , 2007, ALTEX.
[57] V. Rogiers,et al. A review of national public funding programmes in European countries. , 2008, ALTEX.
[58] Thomas Hartung,et al. Food for thought ... on alternative methods for cosmetics safety testing. , 2008, ALTEX.
[59] S. Bremer,et al. The possible impact of human embryonic stem cells on safety pharmacological and toxicological assessments in drug discovery and drug development. , 2008, Current stem cell research & therapy.
[60] Thomas Hartung,et al. Meeting Report: Validation of Toxicogenomics-Based Test Systems: ECVAM–ICCVAM/NICEATM Considerations for Regulatory Use , 2005, Environmental health perspectives.
[61] C. Grindon. The fourth EC report on laboratory animal use--is it sufficiently revealing? , 2005, Alternatives to laboratory animals : ATLA.
[62] Thomas Hartung,et al. Workgroup Report: Incorporating In Vitro Alternative Methods for Developmental Neurotoxicity into International Hazard and Risk Assessment Strategies , 2007, Environmental health perspectives.
[63] Robert Combes,et al. Toxicity testing: creating a revolution based on new technologies. , 2005, Trends in biotechnology.
[64] Melvin E Andersen,et al. Toxicity testing in the 21st century: bringing the vision to life. , 2009, Toxicological sciences : an official journal of the Society of Toxicology.